0001237899-18-000021.txt : 20181214
0001237899-18-000021.hdr.sgml : 20181214
20181214161816
ACCESSION NUMBER: 0001237899-18-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181212
FILED AS OF DATE: 20181214
DATE AS OF CHANGE: 20181214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fenimore Christopher R.
CENTRAL INDEX KEY: 0001697422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 181235778
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-12-12
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001697422
Fenimore Christopher R.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
VP Controller
Common Stock
2018-08-30
5
G
0
50
0.0
D
1421
D
Common Stock
2018-12-12
4
A
0
5000
0.0
A
6421
D
Common Stock
2018-08-30
5
G
0
50
0.0
A
4347
I
By Trust
Common Stock
2018-10-25
5
G
0
2950
0.0
D
1397
I
By Trust
Common Stock
2018-10-25
5
G
0
2950
0.0
A
2950
I
by 2018 GRAT
Common Stock
1349
I
By 401(k) Plan
Common Stock
1424
I
by 2017 GRAT
Non-Qualified Stock Option (right to buy)
381.4
2018-12-12
4
A
0
11400
0.0
A
2028-12-12
Common Stock
11400
11400
D
Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 12, 2023.
These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Christopher R. Fenimore
2018-12-13